Also known as Emcure Pharmaceuticals.
None yet. When a new project in the record names Emcure as owner, partner or investor, it shows here.
Early, multi-faceted plan includes seven royalty‑free licenses covering 129 LMICs, regional manufacturing support in Africa and Latin America, and early manufacturing investment to speed availability.
